• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Recursion Pharmaceuticals

< Previous 1 2 3 Next >
News headline image
Recursion to Participate in Upcoming Investor Conference
April 02, 2024
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Publishes Annual Environmental, Social and Governance Report
March 26, 2024
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
March 01, 2024
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conferences
March 01, 2024
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 27, 2024
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Host Public L(earnings) Call on February 27
February 20, 2024
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Altitude Lab Startups Raise Over $120M in Capital
January 24, 2024
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
January 08, 2024
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
January 03, 2024
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
December 20, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Bayer and Recursion Focus Research Collaboration on Oncology
November 09, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
November 09, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conference
November 02, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conferences
September 05, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
September 05, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds
August 08, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
August 08, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conference
August 01, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships
July 26, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
July 12, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
June 26, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled
June 13, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conferences
June 01, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
May 16, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results
May 08, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
May 08, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conferences
May 02, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conference
April 03, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Recursion Publishes Second Annual Environmental, Social and Governance Report
March 28, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Recursion to Participate in Upcoming Investor Conferences
March 01, 2023
From Recursion Pharmaceuticals
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap